Post Cardiac Arrest Syndrome (PCAS)

Introduction

Post–Cardiac Arrest Syndrome (PCAS) refers to the complex pathophysiological state that develops after Return of Spontaneous Circulation (ROSC) following cardiac arrest. It is a multisystem disorder characterized by global ischemia-reperfusion injury, systemic inflammation, and organ dysfunction.

👉 Mortality after ROSC remains high (≈50–70%)
👉 Neurological injury is the most common cause of death in survivors.

PCAS is analogous to sepsis + ischemia-reperfusion injury + postcardiotomy syndrome occurring simultaneously.

Post-cardiac arrest syndrome includes four major components:

  1. Post-cardiac arrest brain injury
  2. Post-cardiac arrest myocardial dysfunction
  3. Systemic ischemia-reperfusion response
  4. Persistent precipitating pathology


Timeline of PCAS

Phase

Time

Key Features

Immediate

0–20 min

ROSC stabilization

Early

20 min – 6 hrs

Hemodynamic instability, cerebral injury begins

Intermediate

6–72 hrs

Maximum inflammatory and neurological injury

Recovery

>72 hrs

Prognostication phase


Pathophysiology of PCAS

Global Ischemia–Reperfusion Injury

Cardiac arrest causes complete cessation of blood flow, resulting in:

During Cardiac Arrest

  • ATP depletion
  • Cellular ion pump failure
  • Intracellular calcium overload
  • Lactic acidosis
  • Membrane instability

After ROSC (Reperfusion Phase)

  • Oxygen free radical generation
  • Mitochondrial dysfunction
  • Cytokine storm
  • Endothelial injury
  • Microvascular thrombosis

👉 This resembles sepsis-like syndrome


Component 1 – Post-Cardiac Arrest Brain Injury

Pathogenesis

Brain is extremely vulnerable to ischemia.

Mechanisms

  1. Excitotoxicity (glutamate release)
  2. Calcium-mediated neuronal injury
  3. Cerebral edema
  4. Microcirculatory dysfunction
  5. Delayed apoptosis


Clinical Features

Early

  • Coma
  • Seizures
  • Myoclonus
  • Loss of brainstem reflexes

Late

  • Persistent vegetative state
  • Cognitive deficits


Neurological Prognostic Factors

Assessment recommended ≥72 hours after ROSC or after rewarming from TTM.

Poor prognostic indicators:

  • Absent pupillary reflex
  • Bilateral absent N20 SSEP
  • High neuron-specific enolase
  • Diffuse cerebral edema
  • Malignant EEG patterns

Immediately after ROSC, coma and absent brainstem reflexes usually represent transient post-ischemic brain dysfunction — not brain death — hence Brain Stem Death protocol must be delayed


Component 2 – Post-Cardiac Arrest Myocardial Dysfunction

Characteristics

  • Reversible myocardial stunning
  • Occurs within hours after ROSC
  • Peaks 8–24 hrs
  • Usually resolves within 48–72 hrs


Pathophysiology

Mechanisms:

  • Calcium overload
  • Free radical injury
  • Mitochondrial damage
  • Microvascular dysfunction


Clinical Manifestations

  • Low cardiac output state
  • Hypotension
  • Arrhythmias
  • Elevated troponin (without acute MI necessarily)


Management

Guideline-based approach:

Hemodynamic Targets

  • MAP ≥ 65 mmHg
  • Urine output ≥ 0.5 mL/kg/hr
  • Lactate clearance

Pharmacologic Therapy

  • Fluids (balanced crystalloids)
  • Vasopressors (Norepinephrine – first line)
  • Inotropes (Dobutamine if low cardiac output)


Component 3 – Systemic Ischemia-Reperfusion Response

Sepsis-Like Syndrome

Features resemble SIRS:

Mechanisms

  • Cytokine release (IL-6, TNF-α)
  • Endothelial activation
  • Capillary leak
  • Coagulopathy
  • Mitochondrial dysfunction


Clinical Consequences

  • Vasoplegic shock
  • ARDS
  • Acute kidney injury
  • Liver dysfunction
  • Coagulopathy


Component 4 – Persistent Precipitating Cause

Common causes include:

Cause

Examples

Coronary

STEMI, plaque rupture

Arrhythmias

VT/VF

Pulmonary

Massive PE

Metabolic

Hyperkalemia

Toxins

Drug overdose


Post Cardiac Arrest Care Bundle (AHA/ERC Guideline)

1. Oxygenation & Ventilation

Oxygen Targets

  • Avoid hyperoxia
  • Maintain SpO₂ = 92–98%

Ventilation Targets

  • Maintain PaCO₂ 35–45 mmHg
  • Avoid hypocapnia reduces cerebral blood flow


2. Hemodynamic Optimization

Goals:

  • MAP ≥ 65 mmHg
  • ScvO₂ > 70%
  • Lactate clearance

Use:

  • Fluid resuscitation
  • Vasopressors
  • Inotropes


3. Targeted Temperature Management (TTM)

Indications

  • Comatose patients after ROSC

Temperature Targets

Modern guidelines recommend:

👉 Maintain 32–36°C
👉 Avoid fever (>37.7°C)

Duration

  • Maintain ≥24 hrs
  • Controlled rewarming


Mechanisms of Benefit

  • Reduces cerebral metabolism
  • Reduces excitotoxicity
  • Reduces inflammation
  • Stabilizes blood–brain barrier


4. Coronary Reperfusion

Indications

  • STEMI Immediate PCI
  • Suspected coronary cause with shock/arrhythmia


5. Neurological Monitoring

Tools

  • Continuous EEG
  • SSEP
  • Neuroimaging
  • Biomarkers


6. Glycemic Control

Target: 140–180 mg/dL-Avoid hypoglycemia.


7. Seizure Management

  • Common after ROSC
  • Treat with benzodiazepines levetiracetam/valproate


8. Prognostication Strategy

Multimodal approach after:
👉 ≥72 hours
👉 After sedative washout
👉 After rewarming

Includes:

  • Clinical exam
  • EEG
  • Imaging
  • Biomarkers


Complications of PCAS

Organ

Complication

Brain

Hypoxic injury, seizures

Heart

Cardiogenic shock

Lungs

ARDS

Kidney

AKI

Hematologic

DIC

Metabolic

Hyperglycemia


Determinants of Outcome

Cardiac Arrest Factors

  • Witnessed arrest
  • Early CPR
  • Initial shockable rhythm
  • Short downtime

Post-ROSC Factors

  • Quality of ICU care
  • Temperature control
  • Hemodynamic optimization


Post-Cardiac Arrest Outcome Categories

CPC Score

Outcome

1

Good neurological recovery

2

Moderate disability

3

Severe disability

4

Vegetative state

5

Death